IPG Photonics Corporation (0J86.L)
| Previous close | 89.65 |
| Open | 89.75 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 89.24 - 89.75 |
| 52-week range | 84.41 - 139.89 |
| Volume | |
| Avg. volume | 65 |
| Market cap | 48.373M |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | 0.17 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
IPG Photonics Launches Cobot Laser Welding and Cleaning System
Automating Repetitive Steps Helping Companies Improve Productivity and Reduce Operating Costs MARLBOROUGH, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP), the world leader in fiber laser solutions, today announced the launch of an automated cobot laser welding and cleaning system for fabrication and manufacturing industries. Turnkey Laser Automation Made EasyThe new cobot is a fully automated, laser welding and cleaning system which can be configured with any ex
- GlobeNewswire
IPG Photonics Announces First Quarter 2024 Financial Results
Delayed E-mobility Investments and Soft Industrial Demand Negatively Impacted Results Strong Operating Cash Flow Benefited from Working Capital Management MARLBOROUGH, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the first quarter ended March 31, 2024. Three Months Ended March 31, (In millions, except per share data and percentages) 2024 2023 ChangeRevenue $252.0 $347.2 (27)%Gross margin 38.7% 42.3% Operating income $19.1
- GlobeNewswire
IPG Photonics Announces Leadership Transition
Mark Gitin Appointed Next Chief Executive Officer and to Board of Directors Co-Founder Dr. Eugene Scherbakov to Remain a Member of the Board MARLBOROUGH, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) (“IPG” or the “Company”) today announced that its Board of Directors (the “Board”) has appointed Mark Gitin, 57, as the next Chief Executive Officer of the Company and as a member of the Board, effective June 5, 2024. Dr. Gitin’s appointment follows a robust succ
